AstraZeneca tests diabetes drug as possible COVID-19 treatment

(Reuters) - AstraZeneca said on Thursday it has started a late-stage trial testing its diabetes drug Farxiga to reduce the risk of serious complications and organ failure in COVID-19 patients with existing heart and kidney problems. This is the British drugmaker's second trial investigating an existing therapy to help treat the highly contagious respiratory illness caused by the novel coronavirus. The goal is to assess if Farxiga can cut the risk of disease progression, clinical..